Medical Condition News

RSS

ChemoCentryx commences CCX832 Phase I trial in patients with psoriasis

ChemoCentryx, today announced the initiation of a Phase I clinical trial of CCX832, an orally-administered small molecule that is a potent and selective inhibitor of the chemoattractant receptor, ChemR23.

26 Jan 2011

Alcohol-related liver disease rising among young Britons

According to latest National Health Service (NHS) figures the number of people under 30 admitted to hospital in the past decade has risen by more than 50 per cent. 351 people aged 30 and under were admitted to an English hospital with alcohol related liver disease in 2009/10, up from 230 in 2000/01. That is still only a small fraction of the 14,500 people aged 31 or over who were admitted for alcohol-related liver problems in the last year.

26 Jan 2011

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

RNL BIO CO., LTD, a leading biopharmaceutical company specialized in adult stem cell therapeutics, announced on January 21, 2011 another successful patient report utilizing stem cell therapy on a leading US orthopedic spine surgeon who suffered from Autoimmune Arthritis.

26 Jan 2011

Pill for multiple sclerosis in the pipeline

Multiple Sclerosis or MS is a severely disabling disease that affects 100,000 in the UK. Now a new pill has been developed to treat multiple sclerosis which means there would be no need for injections. European health experts - European Medicines Agency (EMA) have given the new drug Gilenya, the brand name for the drug fingolimod, approval which would grant it EU wide acceptance.

25 Jan 2011

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

French researchers determined that infection with human immunodeficiency virus (HIV) impaired results of transplant surgery for liver cancer, with more HIV infected patients dropping off the transplantation wait list. The team found that overall survival and recurrence-free survival was not impacted following liver transplantation in patients with controlled HIV disease.

25 Jan 2011

Evaluating patients for genetic variations impacts adherence to antiviral therapy

In two recent studies, researchers have identified two functional variants in the inosine triphosphatase (ITPA) gene that protect patients with hepatitis C virus (HCV) against anemia brought on by antiviral treatment. The ability to identify those patients protected against treatment-induced anemia will ensure completion of antiviral therapy and successful elimination of the virus.

25 Jan 2011

FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine

BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for its Melanoma Cancer Vaccine in the treatment of stage IIb to IV melanoma, from the FDA's Office of Orphan Products Development. Melanoma is the most deadly form of skin cancer.

25 Jan 2011

Emergent BioSolutions initiates TRU-016 Phase Ib/II study for chronic lymphocytic leukemia

Emergent BioSolutions Inc. today announced the initiation of a Phase Ib/II study (16201) of TRU-016 for chronic lymphocytic leukemia (CLL). TRU-016 is a CD37-directed Small Modular ImmunoPharmaceutical (SMIP™) protein therapeutic in development for the treatment of B-cell malignancies. TRU-016 is being developed in collaboration with Abbott.

25 Jan 2011

Majority of the public favor physician-assisted suicide for terminally ill patients in great pain

A new Harris/BBC World News America poll finds that large majorities of Americans now favor physician assisted suicide and euthanasia for terminally ill patients in great pain who wish to end their lives. It also finds that a majority of people over 65 now have written directives regarding the type of care they would like to receive, or not to receive, at the end stages of their lives.

25 Jan 2011

Massive drinks mean massive calories

When you're ordering the new Starbucks "trenta" you're not only getting a massive drink (31 ounces) but massive calories (up to 600) - with the potential to pack on more than 60 extra pounds in one year.

25 Jan 2011

IRIS International places 40 iQ200 Elite Automated Urine Microscopy Analyzers in Mexico in 2010

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory,has begun to significantly penetrate the Mexican healthcare market with the initial placement in 2010 of 40 iQ®200 Elite™ Automated Urine Microscopy Analyzers within one of the largest social security healthcare systems in Mexico.

25 Jan 2011

NINDS awards AndroScience $3.8M cooperative translational research grant for Kennedy's Disease

AndroScience Corp., based in San Diego, California, announced receiving a $3.8 Million, 3-year milestone-driven, cooperative translational research grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH).

25 Jan 2011

California jury awards $2.2 million in defective laparoscopic device case

Encision Inc. – A California jury awarded $2.2 million to a patient in a personal injury, product liability, defective laparoscopic device case against a competing medical device company; as reported in the Daily Journal.

25 Jan 2011

80% of NFL lineman back in game after disc surgery

NFL linemen can recover from back surgery and return to their spine-bruising careers, so can you get back into your "game" of horsing around with your kids or working out at the gym after back surgery.

25 Jan 2011

Northwest Biotherapeutics resumes enrollment in DCVax Phase II brain cancer clinical trial

Cutting edge, patient-specific vaccine treatments like DCVax® provide for a longer life expectancy along with a better quality of life for brain cancer patients, an improvement over current conventional brain tumor treatments. "The vaccine that I received has extended the median survival of Grade IV brain cancer (GBM) from 14.6 months, with conventional treatment, to over 36 months," stated Bob Gibbs, a 7 year brain cancer survivor, who has defied the odds statistically, thanks to the experimental brain cancer vaccine DCVax®.

25 Jan 2011

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Genomic Health, Inc. today announced presentation of three studies at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

25 Jan 2011

Florida Society of Pain Management Providers commends new Pain Clinic regulations / Standards of Care

The Florida Society of Pain Management Providers commends the Florida Board of Medicine and the Florida Board of Osteopathic Medicine in their issuances of Pain Clinic regulations / Standards of Care.

25 Jan 2011

Taiwanese research team develops large-scale proactive cancer treatment system first-generation prototype

A Taiwanese research team, led by Prof. Ming-Shing Young of Department of Electrical Engineering at National Cheng Kung University (NCKU), has successfully developed a large-scale proactive cancer treatment system first-generation prototype which includes Frequency-Adjustable High Frequency Induction Heating Machine (HFIHM) and 3D Magnetically Guiding Endoscope System (3DMGES).

25 Jan 2011

Kira For Women introduces two new products for menopause, PMS

Natural women's health brand, Kira For Women, is launching two new products - Kira PMS Relief and Kira Menopause Relief.

25 Jan 2011

Study finds heart failure diagnosis four times higher in most economically disadvantaged communities

Heart failure diagnosis is four times higher in the most economically disadvantaged communities and twice as high among South Asians a new study at the University of Leicester has found.

25 Jan 2011

Medical Condition News

ChemoCentryx commences CCX832 Phase I trial in patients with psoriasis

Alcohol-related liver disease rising among young Britons

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

Pill for multiple sclerosis in the pipeline

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

Evaluating patients for genetic variations impacts adherence to antiviral therapy

FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine

Emergent BioSolutions initiates TRU-016 Phase Ib/II study for chronic lymphocytic leukemia

Majority of the public favor physician-assisted suicide for terminally ill patients in great pain

Massive drinks mean massive calories

IRIS International places 40 iQ200 Elite Automated Urine Microscopy Analyzers in Mexico in 2010

NINDS awards AndroScience $3.8M cooperative translational research grant for Kennedy's Disease

California jury awards $2.2 million in defective laparoscopic device case

80% of NFL lineman back in game after disc surgery

Northwest Biotherapeutics resumes enrollment in DCVax Phase II brain cancer clinical trial

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Florida Society of Pain Management Providers commends new Pain Clinic regulations / Standards of Care

Taiwanese research team develops large-scale proactive cancer treatment system first-generation prototype

Kira For Women introduces two new products for menopause, PMS

Study finds heart failure diagnosis four times higher in most economically disadvantaged communities

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News